Adi Ramakrishna is currently the Senior Director of Medical Access Strategy at Pfizer Oncology, where they oversee pathway and compendia submission strategy. With ten years of experience in oncology, Adi has developed strong relationships with national and regional payer decision-makers and has successfully launched five oncology drugs. Previously, they held roles at Seagen and Eli Lilly, including Senior Clinical Value and Outcomes Liaison and Senior Sales Representative, respectively. Adi's education includes a Pharm.D. and a Master's in Industrial Administration from Purdue University.
This person is not in any teams
This person is not in any offices